Andrew W. Mulcahy — Publications

View Profile »

Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data

2024
Comparing New Prescription Drug Availability and Launch Timing in the United States and Other OECD Countries

2024
Ground Ambulance Industry Trends, 2017-2020: Analysis of Medicare Fee-for-Service Claims

2024
Ground Ambulance Industry Trends, 2017–2022: An Analysis of Ground Ambulance Organization Entrance and Exit

2024
International Prescription Drug Price Comparisons: Estimates Using 2022 Data

2024
Prescription Drug Prices, Rebates, and Insurance Premiums

2024
Impact of Drug Shortages on Consumer Costs

2023
Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

2023
Projected US Savings From Biosimilars, 2021–2025

2022
Assessing Relationships Between Drug Shortages in the United States and Other Countries

2021
Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit

2021
Claims-Based Reporting of Post-Operative Visits for Procedures with 10- or 90-Day Global Periods: Updated Results Using Calendar Year 2018 Data

2021
Claims-Based Reporting of Post-Operative Visits for Procedures with 10- or 90-Day Global Periods: Updated Results Using Calendar Year 2019 Data

2021
Claims-Based Reporting of Post-Operative Visits for Procedures with 10- or 90-Day Global Periods: Final Report

2021
Estimated Savings from International Reference Pricing for Prescription Drugs

2021
Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results

2021
International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies

2021
Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships

2021
Responses to Comments on RAND Global Services Reports

2021
Using Claims-Based Estimates of Post-Operative Visits to Revalue Procedures with 10- and 90-Day Global Periods

2021
Using Claims-Based Estimates of Post-Operative Visits to Revalue Procedures with 10- and 90-Day Global Periods: Updated Results Using Calendar Year 2019 Data

2021
U.S. Prescription Drug Prices Are 2.5 Times Those in Other OECD Countries

2021
Comparing Insulin Prices in the United States to Other Countries: Results from a Price Index Analysis

2020
Evaluation of California Senate Bill 863 Medical Care Reforms

2020
Patterns of Postoperative Visits Among Medicare Fee-for-service Beneficiaries

2020
Payment for Services Rendered: Updating Medicare's Valuation of Procedures

2020
Subscription Models for Prescription Drugs: The Motivation, Potential, and Limitations of a New Payment Model

2020
Measuring Health Care Utilization in Medicare Advantage Encounter Data: Methods, Estimates, and Considerations for Research

2019
Survey-Based Reporting of Post-Operative Visits for Select Procedures with 10- or 90-Day Global Periods: Final Report

2019
Access to Medical Treatment for Injured Workers in California: Year 2 Annual Report

2018
Access to Medical Treatment for Injured Workers in California: Year 1 Annual Report

2018
Early Impact of the Affordable Care Act Coverage Expansion on Safety-Net Hospital Inpatient Payer Mix and Market Shares

2018
Medical Care Provided to California's Injured Workers: Monitoring System Performance Using Administrative Data

2018
Medical Costs for Osteoporosis-Related Fractures in High-Risk Medicare Beneficiaries

2018
Biosimilar Cost Savings in the United States: Initial Experience and Future Potential

2017
Estimating the Long-Term Functional Burden of Osteoporosis-Related Fractures

2017
The Impact of Health Reform on Purchased Care Access: National Health Reform and Modernization of the Military Health System Study

2017
Modeling the Economic Impact of a California Workers' Compensation Formulary

2017
Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics

2017
Variation in Dermatologist Visits by Sociodemographic Characteristics

2017
Avoiding the Tragedy of the Commons in Health Care: Policy Options for Covering High-Cost Cures

2016
Building a More Sustainable U.S. Blood System

2016
Effect of Teledermatology on Access to Dermatology Care Among Medicaid Enrollees

2016
Estimating Surgical Procedure Times Using Anesthesia Billing Data and Operating Room Records

2016
Gaining Coverage Through Medicaid or Private Insurance Increased Prescription Use and Lowered Out-of-Pocket Spending

2016
Implementing a Drug Formulary for California's Workers' Compensation Program

2016
Toward a Sustainable Blood Supply in the United States: An Analysis of the Current System and Alternatives for the Future

2016
Access and Quality of Care in Direct-To-Consumer Telemedicine

2015
Antibiotic Prescribing for Acute Respiratory Infections in Direct-to-Consumer Telemedicine Visits

2015
Current and Projected Characteristics and Unique Health Care Needs of the Patient Population Served by the Department of Veterans Affairs

2015
Development of a Model for the Validation of Work Relative Value Units for the Medicare Physician Fee Schedule

2015
Early Marketplace Enrollees Were Older and Used More Medication Than Later Enrollees: Marketplaces Pooled Risk

2015
Medicare's Step Back from Global Payments: Unbundling Postoperative Care

2015
RAND Modeling Offers Support for Transparent and Consistent CMS Physician Fee Schedules

2015
Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report

2015
Specialty Payment Model Opportunities and Assessment: Oncology Simulation Report

2015
Specialty Payment Model Opportunities and Assessment: Gastroenterology and Cardiology Model Design Report

2015
The 340B Prescription Drug Discount Program: Origins, Implementation, and Post-Reform Future

2014
The Cost Savings Potential of Biosimilar Drugs in the United States

2014
Fee Schedule Options for Services Furnished by Hospitals to Outpatients under the California Workers' Compensation Program

2014
Healing Medical Product Innovation

2014
Health Sector Reform in the Kurdistan Region — Iraq: Financing Reform, Primary Care, and Patient Safety (Arabic-language version)

2014
Health Sector Reform in the Kurdistan Region — Iraq: Financing Reform, Primary Care, and Patient Safety (Kurdish-language version)

2014
Health Sector Reform in the Kurdistan Region — Iraq: Financing Reform, Primary Care, and Patient Safety

2014
Implementing a Resource-Based Relative Value Scale Fee Schedule for Physician Services: An Assessment of Policy Options for the California Workers' Compensation Program

2014
Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value

2014
The Relationship Between Influenza Vaccination Habits and Location of Vaccination

2014
Development of a framework to estimate the cost of opioid dependence

2013
Insurance Coverage of Emergency Care for Young Adults Under Health Reform

2013
The New Neglected Diseases? Policy Interventions Are Needed to Encourage CNS Drug Development

2013
Flattening the Trajectory of Health Care Spending: Facilitate High-Value Innovation

2012
Flattening the Trajectory of Health Care Spending: Foster Efficient and Accountable Providers

2012
Flattening the Trajectory of Health Care Spending: Engage and Empower Consumers

2012
Flattening the Trajectory of Health Care Spending: Insights from RAND Health Research

2012
Flattening the Trajectory of Health Care Spending: Promote Population Health

2012

Federally Funded Research Divisions

Social and Economic Policy Divisions

International

Andrew W. Mulcahy — Publications

Comparing Insulin Prices in the United States to Other Countries: Updated Results Using 2022 Data

Comparing New Prescription Drug Availability and Launch Timing in the United States and Other OECD Countries

Ground Ambulance Industry Trends, 2017-2020: Analysis of Medicare Fee-for-Service Claims

Ground Ambulance Industry Trends, 2017–2022: An Analysis of Ground Ambulance Organization Entrance and Exit

International Prescription Drug Price Comparisons: Estimates Using 2022 Data

Prescription Drug Prices, Rebates, and Insurance Premiums

Impact of Drug Shortages on Consumer Costs

Impacts of increasing requirements for research and development (R&D) cost transparency: Literature review

Projected US Savings From Biosimilars, 2021–2025

Assessing Relationships Between Drug Shortages in the United States and Other Countries

Balancing Access and Cost Control in the TRICARE Prescription Drug Benefit

Claims-Based Reporting of Post-Operative Visits for Procedures with 10- or 90-Day Global Periods: Updated Results Using Calendar Year 2018 Data

Claims-Based Reporting of Post-Operative Visits for Procedures with 10- or 90-Day Global Periods: Updated Results Using Calendar Year 2019 Data

Claims-Based Reporting of Post-Operative Visits for Procedures with 10- or 90-Day Global Periods: Final Report

Estimated Savings from International Reference Pricing for Prescription Drugs

Estimating the Cost of Industry Investment in Drug Research and Development: A Review of Methods and Results

International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies

Prescription Drug Supply Chains: An Overview of Stakeholders and Relationships

Responses to Comments on RAND Global Services Reports

Using Claims-Based Estimates of Post-Operative Visits to Revalue Procedures with 10- and 90-Day Global Periods

Using Claims-Based Estimates of Post-Operative Visits to Revalue Procedures with 10- and 90-Day Global Periods: Updated Results Using Calendar Year 2019 Data

U.S. Prescription Drug Prices Are 2.5 Times Those in Other OECD Countries

Comparing Insulin Prices in the United States to Other Countries: Results from a Price Index Analysis

Evaluation of California Senate Bill 863 Medical Care Reforms

Patterns of Postoperative Visits Among Medicare Fee-for-service Beneficiaries

Payment for Services Rendered: Updating Medicare's Valuation of Procedures

Subscription Models for Prescription Drugs: The Motivation, Potential, and Limitations of a New Payment Model

Measuring Health Care Utilization in Medicare Advantage Encounter Data: Methods, Estimates, and Considerations for Research

Survey-Based Reporting of Post-Operative Visits for Select Procedures with 10- or 90-Day Global Periods: Final Report

Access to Medical Treatment for Injured Workers in California: Year 2 Annual Report

Access to Medical Treatment for Injured Workers in California: Year 1 Annual Report

Early Impact of the Affordable Care Act Coverage Expansion on Safety-Net Hospital Inpatient Payer Mix and Market Shares

Medical Care Provided to California's Injured Workers: Monitoring System Performance Using Administrative Data

Medical Costs for Osteoporosis-Related Fractures in High-Risk Medicare Beneficiaries

Biosimilar Cost Savings in the United States: Initial Experience and Future Potential

Estimating the Long-Term Functional Burden of Osteoporosis-Related Fractures

The Impact of Health Reform on Purchased Care Access: National Health Reform and Modernization of the Military Health System Study

Modeling the Economic Impact of a California Workers' Compensation Formulary

Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics

Variation in Dermatologist Visits by Sociodemographic Characteristics

Avoiding the Tragedy of the Commons in Health Care: Policy Options for Covering High-Cost Cures

Building a More Sustainable U.S. Blood System

Effect of Teledermatology on Access to Dermatology Care Among Medicaid Enrollees

Estimating Surgical Procedure Times Using Anesthesia Billing Data and Operating Room Records

Gaining Coverage Through Medicaid or Private Insurance Increased Prescription Use and Lowered Out-of-Pocket Spending

Implementing a Drug Formulary for California's Workers' Compensation Program

Toward a Sustainable Blood Supply in the United States: An Analysis of the Current System and Alternatives for the Future

Access and Quality of Care in Direct-To-Consumer Telemedicine

Antibiotic Prescribing for Acute Respiratory Infections in Direct-to-Consumer Telemedicine Visits

Current and Projected Characteristics and Unique Health Care Needs of the Patient Population Served by the Department of Veterans Affairs

Development of a Model for the Validation of Work Relative Value Units for the Medicare Physician Fee Schedule

Early Marketplace Enrollees Were Older and Used More Medication Than Later Enrollees: Marketplaces Pooled Risk

Medicare's Step Back from Global Payments: Unbundling Postoperative Care

RAND Modeling Offers Support for Transparent and Consistent CMS Physician Fee Schedules

Specialty Payment Model Opportunities and Assessment: Oncology Model Design Report

Specialty Payment Model Opportunities and Assessment: Oncology Simulation Report

Specialty Payment Model Opportunities and Assessment: Gastroenterology and Cardiology Model Design Report

The 340B Prescription Drug Discount Program: Origins, Implementation, and Post-Reform Future

The Cost Savings Potential of Biosimilar Drugs in the United States

Fee Schedule Options for Services Furnished by Hospitals to Outpatients under the California Workers' Compensation Program

Healing Medical Product Innovation

Health Sector Reform in the Kurdistan Region — Iraq: Financing Reform, Primary Care, and Patient Safety (Arabic-language version)

Health Sector Reform in the Kurdistan Region — Iraq: Financing Reform, Primary Care, and Patient Safety (Kurdish-language version)

Health Sector Reform in the Kurdistan Region — Iraq: Financing Reform, Primary Care, and Patient Safety

Implementing a Resource-Based Relative Value Scale Fee Schedule for Physician Services: An Assessment of Policy Options for the California Workers' Compensation Program

Redirecting Innovation in U.S. Health Care: Options to Decrease Spending and Increase Value

The Relationship Between Influenza Vaccination Habits and Location of Vaccination

Development of a framework to estimate the cost of opioid dependence

Insurance Coverage of Emergency Care for Young Adults Under Health Reform

The New Neglected Diseases? Policy Interventions Are Needed to Encourage CNS Drug Development

Flattening the Trajectory of Health Care Spending: Facilitate High-Value Innovation

Flattening the Trajectory of Health Care Spending: Foster Efficient and Accountable Providers

Flattening the Trajectory of Health Care Spending: Engage and Empower Consumers

Flattening the Trajectory of Health Care Spending: Insights from RAND Health Research

Flattening the Trajectory of Health Care Spending: Promote Population Health